ASX:DXS DEXUS (DXS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About DEXUS Stock (ASX:DXS) 30 days 90 days 365 days Advanced Chart Remove Ads Get DEXUS alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume5.01 million shsAverage VolumeN/AMarket Capitalization$8.03 billionP/E Ratio16.80Dividend Yield5.39%Price TargetN/AConsensus RatingN/A Company OverviewDexus (ASX: DXS) is a leading Australasian fully integrated real asset group, managing a high-quality Australasian real estate and infrastructure portfolio valued at $61.0 billion (pro forma post final completion of the AMP Capital acquisition). We believe that the strength and quality of our relationships will always be central to our success and are deeply connected to our purpose: Unlock potential, create tomorrow. We directly and indirectly own $17.4 billion of office, industrial, healthcare, retail and infrastructure assets and investments. We manage a further $43.6 billion of investments in our funds management business (pro forma post final completion of the AMP Capital acquisition) which provides third party capital with exposure to quality sector specific and diversified real asset products. The funds within this business have a strong track record of delivering performance and benefit from Dexus's capabilities. The group's $17.4 billion real estate development pipeline provides the opportunity to grow both portfolios and enhance future returns. Our sustainability aspiration is to unlock the potential of real assets to create lasting positive impact and a more sustainable tomorrow, and is focused on the priorities of customer prosperity, climate action and enhancing communities. Dexus is supported by more than 34,000 investors from 25 countries. With four decades of expertise in property investment, funds management, asset management and development, we have a proven track record in capital and risk management and delivering returns for investors.Read More… Remove Ads Receive DXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DEXUS and its competitors with MarketBeat's FREE daily newsletter. Email Address DXS Stock News HeadlinesWhat we learnt: The ASX giants sweating on rate cutsFebruary 18, 2025 | afr.comDexus pitches Australia as safe haven, plans A$2 billion asset saleFebruary 17, 2025 | reuters.comDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.March 26, 2025 | Brownstone Research (Ad)Where to find the 'cheapest' shares on the ASXFebruary 4, 2025 | msn.comASX Broker Moves: Upgrades for Fortescue, Wesfarmers, Aristocrat Leisure vs Downgrades for Goodman Group, Stockland, Sigma HealthcareJanuary 29, 2025 | msn.comAnalysts name 3 ASX dividend shares to buy in JanuaryJanuary 7, 2025 | fool.com.auASX Market Open: Rate cut calls here again to (slightly) dampen record-bound Christmas bull run | Dec 9, 2024December 9, 2024 | msn.comDexus AGM Highlights Leadership Transition and Strategic GrowthOctober 31, 2024 | markets.businessinsider.comSee More Headlines DXS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of DEXUS own? Based on aggregate information from My MarketBeat watchlists, some other companies that DEXUS investors own include Medibank Private (MPL), Accenture (ACN), AECOM (ACM), Accel Entertainment (ACEL), Abbott Laboratories (ABT), Abacus Property Group (ABP) and AbbVie (ABBV). Company Calendar Ex-Dividend for 2/27 Dividend12/29/2024Dividend Payable2/27/2025Today3/26/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorReal Estate Industry REIT - Office Sub-IndustryN/A Current SymbolASX:DXS CIKN/A Webwww.dexus.com Phone+61-2-90171100FaxN/AEmployees1,079Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($1.47) Trailing P/E Ratio16.80 Forward P/E RatioN/A P/E Growth3.87Net Income$-1,580,000,000.00 Net Margins49.62% Pretax MarginN/A Return on Equity4.44% Return on Assets-0.80% Debt Debt-to-Equity Ratio49.23 Current Ratio0.95 Quick Ratio0.44 Sales & Book Value Annual Sales$338.30 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow175.29 Book ValueA$9.45 per share Price / BookN/AMiscellaneous Outstanding Shares1,080,000,000Free FloatN/AMarket Cap$8.03 billion OptionableNot Optionable Beta0.81 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (ASX:DXS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DEXUS Please log in to your account or sign up in order to add this asset to your watchlist. Share DEXUS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.